The diagnostic model established with the indicators of both types of fluorescence intensity presents better performance than AFP for differentiating HCC from BLD, and the diagnostic model that combined the fluorescence indicators, AFP, hepatic function tests and age exhibited excellent performance for differentiating HCC from BLD, with an AUROC greater than 0.95 and an accuracy more than 90%. The gene discussed is AFP; the disease is hepatocellular carcinoma.